Effects of testosterone [Androgel] replacement on atherosclerosis progression in older men with low testosterone levels.

Trial Profile

Effects of testosterone [Androgel] replacement on atherosclerosis progression in older men with low testosterone levels.

Completed
Phase of Trial: Phase IV

Latest Information Update: 06 Jul 2017

At a glance

  • Drugs Testosterone (Primary)
  • Indications Hypogonadism
  • Focus Therapeutic Use
  • Acronyms TEAAM
  • Most Recent Events

    • 04 Apr 2017 Results from 2 randomized trials (TAP and TEAAM) presented at The 99th Annual Meeting of the Endocrine Society
    • 19 Dec 2016 Results of two studies (TAP and TEAAM) published in the Journal of Clinical Endocrinology and Metabolism
    • 19 Dec 2016 Status changed from active, no longer recruiting to completed according to results published in the Journal of Clinical Endocrinology and Metabolism.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top